Login Register Cart 0
Generic placeholder image

Current Indian Science

Editor-in-Chief

ISSN (Print): 2210-299X
ISSN (Online): 2210-3007

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

A Comprehensive Review on Management and Treatment of Arthritis Specially Emphasizing Treatment with Transdermal Patch

Author(s): Ranjan Kirtania, Rizwana Parvin, Sayan Barman, Shreyasi Chakraborty, Laboni Das and Kajal Ghosal*

Volume 1, 2023

Published on: 07 November, 2023

Article ID: e2210299X276015 Pages: 13

DOI: 10.2174/012210299X276015231102052904

Price: $

conference banner
Abstract

Arthritis is one of the major inflammatory diseases and is a global issue. Arthritis is currently an utmost public health problem and it severely affects impact the life of the geriatric population. There are several types of arthritis such as Rheumatoid arthritis, Osteoarthritis, Gout, and Fibromyalgia, which limit the mobility of the patient. In most cases, the reason for the disease is not known clearly and available treatment can reduce the symptoms but cannot cure it completely. Though Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), glucocorticoids, and Disease Modifying Anti Rheumatic Drugs (DMARDs) are the first-line treatments available in arthritis, gastrointestinal discomfort, low solubility, strong first-pass metabolism, low bioavailability, and systemic adverse reactions are the main drawbacks related to these drugs when used in long-term. Based on the evidence related to side effects of the current treatment methodology, several recent studies and developments have been designed and summarized in this field. From these studies, it has been observed that the transdermal drug delivery system can minimize the side effects associated with the oral dosage forms and can deliver the drug directly to the target site along with controlled and prolonged drug release. Hence, novel approaches in transdermal drug delivery systems like transdermal patches and microneedle therapy could be an alternative approach in the treatment and management of arthritis.

[1]
Mohanty, S.; Panda, S.; Bhanja, A.; Pal, A.; Chandra, S.S. Novel drug delivery systems for rheumatoid arthritis: an approach to better patient compliance. Biomed. Pharmacol. J., 2019, 12(1), 157-170.
[http://dx.doi.org/10.13005/bpj/1624]
[2]
Hunter, D.J.; Felson, D.T. Osteoarthritis. BMJ, 2006, 332(7542), 639-642.
[http://dx.doi.org/10.1136/bmj.332.7542.639] [PMID: 16543327]
[3]
Arthritis Health Education. Available from:https://www.arthritis.org/about-arthritis
[4]
Senthelal, S. Arthritis; StatPearls https://www.ncbi.nlm.nih.gov/books/ NBK518992/
[5]
Wang, J.; Zeng, J.; Liu, Z.; Zhou, Q.; Wang, X.; Zhao, F.; Zhang, Y.; Wang, J.; Liu, M.; Du, R. Promising strategies for transdermal delivery of arthritis drugs: Microneedle systems. Pharmaceutics, 2022, 14(8), 1736.
[http://dx.doi.org/10.3390/pharmaceutics14081736] [PMID: 36015362]
[6]
Roseti, L.; Desando, G.; Cavallo, C.; Petretta, M.; Grigolo, B. Articular cartilage regeneration in osteoarthritis. Cells, 2019, 8(11), 1305.
[http://dx.doi.org/10.3390/cells8111305] [PMID: 31652798]
[7]
Bullock, J.; Rizvi, S.A.A.; Saleh, A.M.; Ahmed, S.S.; Do, D.P.; Ansari, R.A.; Ahmed, J. Rheumatoid arthritis: A brief overview of the treatment. Med. Princ. Pract., 2018, 27(6), 501-507.
[http://dx.doi.org/10.1159/000493390] [PMID: 30173215]
[8]
Treatments for Osteoarthritis. Available from:https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/treatments-for-osteoarthritis
[9]
Your RA is in Remission! Now What?. Available from:https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/your-ra-is-in-remission!-now-what
[10]
Radu, A.F.; Bungau, S.G. Management of rheumatoid arthritis: An overview. Cells, 2021, 10(11), 2857.
[http://dx.doi.org/10.3390/cells10112857] [PMID: 34831081]
[11]
Gaffo, A.; Saag, K.G.; Curtis, J.R. Treatment of rheumatoid arthritis. Am. J. Health Syst. Pharm., 2006, 63(24), 2451-2465.
[http://dx.doi.org/10.2146/ajhp050514] [PMID: 17158693]
[12]
D’Arcy, Y.; Mantyh, P.; Yaksh, T.; Donevan, S.; Hall, J.; Sadrarhami, M.; Viktrup, L. Treating osteoarthritis pain: Mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies. Postgrad. Med., 2021, 133(8), 879-894.
[http://dx.doi.org/10.1080/00325481.2021.1949199] [PMID: 34252357]
[13]
Kidd, B.L.; Langford, R.M.; Wodehouse, T. Arthritis and pain. Current approaches in the treatment of arthritic pain. Arthritis Res. Ther., 2007, 9(3), 214.
[http://dx.doi.org/10.1186/ar2147] [PMID: 17572915]
[14]
Gul, R.; Jahan, F.; Naseer, F. Emerging role of chondroitin sulfate based nanocarriers in improving the therapeutic outcome of NSAIDs in the treatment of osteoarthritis through the TDDDS. J. Shifa Tameer-e-Millat Univ., 2021, 4(1), 55-65.
[http://dx.doi.org/10.32593/jstmu/Vol4.Iss1.133]
[15]
Jeong, W.Y.; Kwon, M.; Choi, H.E.; Kim, K.S. Recent advances in transdermal drug delivery systems: a review. Biomater. Res., 2021, 25(1), 24.
[http://dx.doi.org/10.1186/s40824-021-00226-6] [PMID: 34321111]
[16]
Jain, N.K. Controlled and Novel Drug Delivery; CBS Publishers &Distributors Pvt Limited, 2019.
[17]
Akhtar, N.; Singh, V.; Yusuf, M.; Khan, R. A. Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed. Eng., 2020, 65(3), 243-272.
[http://dx.doi.org/10.1515/bmt-2019-0019]
[18]
Chellathurai, M.S.; Ling, V.W.; Palanirajan, V. Fabrication and evaluation of transdermal microneedles for a recombinant human keratinocyte growth factor. Turk. J. Pharmaceut. Sci., 2021, 18(1), 96-103.
[http://dx.doi.org/10.4274/tjps.galenos.2020.21033] [PMID: 33634684]
[19]
Jung, J.H.; Jin, S.G. Microneedle for transdermal drug delivery: current trends and fabrication. J. Pharm. Investig., 2021, 51(5), 503-517.
[http://dx.doi.org/10.1007/s40005-021-00512-4] [PMID: 33686358]
[20]
Zhao, W.; Zheng, L.; Yang, J.; Ma, Z.; Tao, X.; Wang, Q. Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis. Drug Deliv., 2023, 30(1), 121-132.
[http://dx.doi.org/10.1080/10717544.2022.2157518] [PMID: 36533887]
[21]
Shu, Z.; Cao, Y.; Tao, Y.; Liang, X.; Wang, F.; Li, Z.; Li, Z.; Gui, S. Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism. Drug Deliv., 2020, 27(1), 642-651.
[http://dx.doi.org/10.1080/10717544.2020.1754524] [PMID: 32329377]
[22]
Tekko, I.A.; Chen, G.; Domínguez-Robles, J.; Thakur, R.R.S.; Hamdan, I.M.N.; Vora, L.; Larrañeta, E.; McElnay, J.C.; McCarthy, H.O.; Rooney, M.; Donnelly, R.F. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate. Int. J. Pharm., 2020, 586, 119580.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119580] [PMID: 32593650]
[23]
Liu, C.; Guan, Y.; Tian, Q.; Shi, X.; Fang, L. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch. Int. J. Pharm., 2019, 572, 118800.
[http://dx.doi.org/10.1016/j.ijpharm.2019.118800] [PMID: 31678378]
[24]
Kandil, L.S.; Hanafy, A.S.; Abdelhady, S.A. Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model. Drug Dev. Ind. Pharm., 2020, 46(6), 1-9.
[http://dx.doi.org/10.1080/03639045.2020.1764025] [PMID: 32378971]
[25]
Khan, D.; Qindeel, M.; Ahmed, N.; Khan, A.U.; Khan, S.; Rehman, A. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. Nanomedicine, 2020, 15(6), 603-624.
[http://dx.doi.org/10.2217/nnm-2019-0385] [PMID: 32098563]
[26]
Huang, D.; Sun, M.; Bu, Y.; Luo, F.; Lin, C.; Lin, Z.; Weng, Z.; Yang, F.; Wu, D. Microcapsule-embedded hydrogel patches for ultrasound responsive and enhanced transdermal delivery of diclofenac sodium. J. Mater. Chem. B Mater. Biol. Med., 2019, 7(14), 2330-2337.
[http://dx.doi.org/10.1039/C8TB02928H] [PMID: 32254681]
[27]
Song, H.; Wen, J.; Li, H.; Meng, Y.; Zhang, Y.; Zhang, N.; Zheng, W. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int. J. Nanomedicine, 2019, 14, 3177-3188.
[http://dx.doi.org/10.2147/IJN.S188842] [PMID: 31118630]
[28]
Patel, A.; Solanki, R.; Jain, S.; Dangi, Y. S.; Dubey, N. Formulation, development and evaluation of etoricoxib containing transdermal patches in arthritis management. IJRAR, 2018, 5(4), 242-249.
[29]
Vandana, K.R.; Yalavarthi, P.; Sundaresan, C.R.; Sriramaneni, R.; Vadlamudi, H. In-vitro assessment and pharmacodynamics of nimesulide incorporated Aloe vera transemulgel. Curr. Drug Discov. Technol., 2014, 11(2), 162-167.
[http://dx.doi.org/10.2174/1570163810666131202233721] [PMID: 24295369]
[30]
Prausnitz, M.R.; Langer, R. Transdermal drug delivery. Nat. Biotechnol., 2008, 26(11), 1261-1268.
[http://dx.doi.org/10.1038/nbt.1504] [PMID: 18997767]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy